Can blood amyloid levels be used as a biomarker for Alzheimer’s disease?

Alzheimer’s disease (AD) increasingly affects society due to aging populations. Even at pre‐clinical stages, earlier and accurate diagnoses are essential for optimal AD management and improved clin...